Fig. 6From: Computational insight to design new potential hepatitis C virus NS5B polymerase inhibitors with drug-likeness and pharmacokinetic ADMET parameters predictionsA 3D diagram for the interaction of reference molecule R (dasabuvir) in complex with the target receptor (hepatitis C virus NS5B RNA polymerase, PDB ID: 4MKA), B 2D diagram for the interaction of reference molecule R (dasabuvir) in complex with the target receptor (hepatitis C virus NS5B RNA polymerase)Back to article page